TransMedics Group, Inc.
TMDX
$93.50
-$0.68-0.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 62.64% | -65.43% | -0.02% | 202.58% | 115.86% |
| Total Depreciation and Amortization | 9.72% | 12.57% | 6.90% | 19.33% | 90.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.72% | -0.40% | 7.18% | 31.07% | -80.66% |
| Change in Net Operating Assets | 48.16% | -6,455.37% | 100.63% | -405.41% | 64.22% |
| Cash from Operations | 186.76% | -73.34% | 848.70% | -141.37% | 220.91% |
| Capital Expenditure | 71.77% | -102.85% | 46.20% | -5.63% | 61.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 71.51% | -100.99% | 46.20% | -5.63% | 72.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.91% | -26.12% | 234.10% | 244.70% | -39.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.91% | -26.12% | 234.10% | 244.70% | -39.33% |
| Foreign Exchange rate Adjustments | -277.98% | 722.58% | 64.16% | -159.25% | 264.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.08% | -360.55% | 128.11% | -38.07% | 79.21% |